Bacteraemia due to Stenotrophomonas maltophilia:: An analysis of 45 episodes

被引:119
作者
Friedman, ND
Korman, TM
Fairley, CK
Franklin, JC
Spelman, DW
机构
[1] Alfred Hosp, Dept Infect Dis & Microbiol, Prahran, Vic 3181, Australia
[2] Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia
[3] Univ Melbourne, Dept Publ Hlth, Melbourne, Vic, Australia
关键词
D O I
10.1053/jinf.2002.0978
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Stenotrophomonas maltophilia is an important nosocomial pathogen and a therapeutic challenge. A ten-year review of episodes of bacteraemia due to S. maltophilia was undertaken in light of reports of an increasing frequency of infection. Methods: A retrospective analysis of bloodstream infections due to S. maltophilia at a tertiary care hospital in Melbourne, Australia. Cases were identified via microbiology laboratory reports, and relevant clinical data were collected from the medical record of each patient. Results: Eighty per cent of these 45 episodes were nosocomial. The most common characteristics in cases of bacteraemia were the presence of an indwelling central venous catheter (CVC) (38/45, 84%) and previous antibiotic therapy (33/45, 73%). There were 8 deaths (8/44, 18%) within 7 days of bacteraemia. A significant correlation was found between deaths and a failure to remove the CVC (P=0.01) or treat with appropriate antimicrobials (P=0.01). Antibiotic susceptibility testing revealed that isolates were most sensitive to sulphamethoxazole (80%), chloramphenicol (75.5%) and ceftazidime (64.5%). Conclusions: S. maltophilia is an important pathogen especially in the highly compromised host. Isolation of this organism from a blood culture should prompt a careful review of the patient with particular emphasis on removal of indwelling CVCs and commencement of appropriate antibiotic therapy. (C) 2002 The British Infection Society.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 23 条
[1]   BACTEREMIA CAUSED BY NON-AERUGINOSA-PSEUDOMONAS SPECIES IN A CANCER CENTER [J].
AOUN, M ;
VANDERAUWERA, P ;
DEVLEESHOUWER, C ;
DANEAU, D ;
SERAJ, N ;
MEUNIER, F ;
GERAIN, J .
JOURNAL OF HOSPITAL INFECTION, 1992, 22 (04) :307-316
[2]   REVIEW OF ADVERSE EXPERIENCES AND TOLERABILITY IN THE 1ST 2,516 PATIENTS TREATED WITH IMIPENEM CILASTATIN [J].
CALANDRA, GB ;
BROWN, KR ;
GRAD, LC ;
AHONKHAI, VI ;
WANG, C ;
AZIZ, MA .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (6A) :73-78
[3]   Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia [J].
Denton, M ;
Kerr, KG .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) :57-+
[4]  
ELTING LS, 1990, INFECT CONT HOSP EP, V11, P134
[5]   SEPTICEMIA DUE TO XANTHOMONAS SPECIES AND NON-AERUGINOSA PSEUDOMONAS SPECIES - INCREASING INCIDENCE OF CATHETER-RELATED INFECTIONS [J].
ELTING, LS ;
BODEY, GP .
MEDICINE, 1990, 69 (05) :296-306
[6]   SUSCEPTIBILITY OF PSEUDOMONAS-MALTOPHILIA TO ANTI-MICROBIAL AGENTS, SINGLY AND IN COMBINATION [J].
FELEGIE, TP ;
YU, VL ;
RUMANS, LW ;
YEE, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (06) :833-837
[7]  
FRANKLIN JC, 1988, MED LAB SCI, V45, P225
[8]  
Jang Tsrang-Neng, 1992, Journal of the Formosan Medical Association, V91, P1170
[9]   Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric Gram-negative Bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes [J].
Jones, RN ;
Pfaller, MA ;
Marshall, SA ;
Hollis, RJ ;
Wilke, WW .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) :187-192
[10]  
KHARDORI N, 1990, REV INFECT DIS, V12, P997